Document is current
Any future updates will be listed below
-
Authors
Chiu, Tzu-Yuan https://orcid.org/0000-0001-8702-9268
Lazar, Daniel C.
Wang, Wesley W.
Wozniak, Jacob M.
Jadhav, Appaso M.
Li, Weichao https://orcid.org/0000-0001-6875-7315
Gazaniga, Nathalia
Theofilopoulos, Argyrios N.
Teijaro, John R. https://orcid.org/0000-0001-8280-8887
Parker, Christopher G. https://orcid.org/0000-0001-8509-9289
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI156258, T32AI007244)
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 14 December 2023
First Online: 8 January 2024
Competing interests
: C.G.P., J.R.T., D.C.L. and A.M.J. are inventors on a patent application (WO2021174023) submitted by The Scripps Research Institute that covers small-molecule inhibitors of SLC15A4. C.G.P. and J.R.T. are founders of and scientific advisors to Belharra Therapeutics, a biotechnology company interested in using chemical proteomic methods to develop small-molecule therapeutics. All other authors declare no competing interests.
